FDA declines to approve Neffy epinephrine nasal spray for severe allergic reactions
The Food and Drug Administration on Tuesday did not approve Neffy, an epinephrine nasal spray from drugmaker ARS Pharmaceuticals, keeping the first needle-free option for Americans to treat severe allergic reactions off the market pending more trial data. ARS had expected the FDA to approve Neffy for use in adults and children who weigh more…
Read More “FDA declines to approve Neffy epinephrine nasal spray for severe allergic reactions” »